Please note: Work is currently underway to update content available on this site.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Publication #8164
Reference
MSAN(2024)27
Name
Nortriptyline 10mg/5ml and 25mg/5ml oral solution sugar-free
Categories
Scottish Government
Organization
Scottish Government Health and Social Care Directorates
Keywords
NHS
SCOTLAND
HEALTH BOARDS
PHARMACEUTICAL SERVICES
SUPPLIES
DRUG SHORTAGES
Description
1. Nortriptyline 10mg/5ml oral solution sugar-free has been discontinued; all supplies have now been exhausted.
2. Nortriptyline 25mg/5ml oral solution sugar-free will be discontinued from 1st November 2024.
3. Nortriptyline 10mg and 25mg tablets remain available and can support increased demand.
4. Amitriptyline 10mg/5ml and 25mg/5ml oral solution sugar-free remain available and can support increased demand.
5. Unlicensed specials of nortriptyline 10mg/5ml and 25mg/5ml oral suspension sugar-free are available, lead times vary.
2. Nortriptyline 25mg/5ml oral solution sugar-free will be discontinued from 1st November 2024.
3. Nortriptyline 10mg and 25mg tablets remain available and can support increased demand.
4. Amitriptyline 10mg/5ml and 25mg/5ml oral solution sugar-free remain available and can support increased demand.
5. Unlicensed specials of nortriptyline 10mg/5ml and 25mg/5ml oral suspension sugar-free are available, lead times vary.
Contact Name
Contact Email
Contact Address
Created
2024-05-30 11:25:00
Click to go back to homepage